Diagnosis: |
 From symptoms to underlying diagnosis with the support of imaging |
Diagnostic procedure: |
 Imaging procedures tailored to the clinical problem and patient characteristics |
Prevention/screening: |
 Imaging to improve risk stratification or to detect preclinical disease |
Selection of the right treatment with imaging information |
 Imaging to assess the localisation and extent disease |
 Imaging for functional and biological characterisation of lesions |
 Image-guided biopsy to get specimens for genetic/molecular characterisation |
 Imaging biomarkers to predict response to treatment, recurrence and survival |
 Agents that can be used for imaging diagnostics and therapeutic purposes (theranostics) |
 Imaging biomarkers associated with genetic/molecular features (radiogenomics) |
Evaluation of treatment response: |
 Imaging to assess early the effects of treatment in order to adapt treatment |
Imaging in drug discovery and drug trials: |
 Surrogate imaging biomarkers to evaluate the effect of new personalised treatment |
Personalised treatment: |
 Image-guided treatment with surgical, radiotherapeutical, minimally or non-invasive interventional procedures |